NCT07869732Phase 2Not yet recruiting

(Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty

Study sponsor: Atossa Therapeutics, Inc. · ATOS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-06Estimated
Enrollment · participants6Estimated
Source updated2026-10-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.